FDG-PET is effective in the detection of granulocytic sarcoma in patients with myeloid malignancy

Leukemia Research

Volumn 34, Issue 9, 2010, Pages 1239-1241

  Ueda, Koki ^a   Ichikawa, Motoshi ^a   Takahashi, Miwako ^a   Momose, Toshimitsu ^a   Ohtomo, Kuni ^a   Kurokawa, Mineo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Computer tomography; Myeloid; Positron emission tomography; Sarcoma; SUVmax

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GRANULOCYTIC SARCOMA; HUMAN; INTERMETHOD COMPARISON; MALE; MYELOID LEUKEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EID: 77955268188     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.04.017     Document Type: Article

References (6)

1. Dock G. Chloroma and its relation to leukaemia. Am J Med Sci 1893, 106:152-184.
2. Neiman R.S., Barcos M., Berard C., et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981, 48:1426-1437.
3. Johnson J.L., Moscinski L., Zuckerman K. Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 3. Acute myeloid leukemia presenting with lytic bone lesions. J Clin Oncol 2004, 22:2968-2970.
4. Karlin L., Itti E., Pautas C., et al. PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma. Haematologica 2006, 91:ECR54.
5. Mantzarides M., Bonardel G., Fagot T., et al. Granulocytic sarcomas evaluated with F-18-fluorodeoxyglucose PET. Clin Nucl Med 2008, 33:115-117.
6. Aschoff P., Hantschel M., Oksuz M., et al. Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma. Nuklearmedizin 2009, 48:185-191.